[Genetic similarity of vancomycin resistant strains of Enterococcus faecium isolated from clinical specimens]

Andrzej Młynarczyk1, Wanda Grzybowska, Agnieszka Mrówka

  • 1Katedra i Zakład Mikrobiologii Lekarskiej Warszawskiego Uniwersytetu Medycznego.

Medycyna Doswiadczalna I Mikrobiologia
|April 9, 2011
PubMed

Insights

This study investigated vancomycin-resistant Enterococcus faecium (VRE) strains from hospital patients. Molecular typing revealed a dominant VRE clone primarily circulating in intensive care units.

Area of Science:

  • Microbiology
  • Infectious Diseases
  • Molecular Epidemiology

Context:

  • Vancomycin-resistant Enterococcus faecium (VRE) poses a significant threat in healthcare settings.
  • VRE strains were isolated from patients across three distinct hospital wards between 2005 and 2008.
  • The study focused on intensive therapy, urological, and internistic wards, which have differing patient populations and infection risks.

Purpose:

  • To molecularly characterize VRE isolates from different hospital wards.
  • To determine the genetic relatedness and clonal distribution of VRE strains.
  • To identify the presence of specific vancomycin resistance genes (vanA, vanB, vanD, vanE, vanG).

Summary:

  • Twenty VRE strains were analyzed, all possessing the vanA gene and lacking other van genes.
  • RFLP-PFGE analysis identified a major VRE group (similarity >79.5%) comprising fourteen strains.
  • This dominant group showed highest similarity among strains from intensive therapy patients, with two subgroups exhibiting >93.3% similarity.

Impact:

  • Identified a predominant VRE clone, suggesting potential for nosocomial transmission within and between hospital wards.
  • Highlights the utility of RFLP-PFGE for tracking VRE outbreaks and understanding strain dissemination.
  • Findings can inform infection control strategies to limit VRE spread in hospitals.

Related Concept Videos

Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Development of Antibiotic Resistance01:30

Development of Antibiotic Resistance

Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...